Status in the House for the 92nd Legislature (2021 - 2022)
Prescription drug manufacturer incentive authorized for those importing drugs pursuant to "Pathway 2" of safe importation action plan.
03/08/2021 |
Introduction and first reading, referred to Commerce Finance and Policy
|